Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Infectious Disorders Drug Targets
|
March 8, 2012
Reprogramming of B cells into regulatory cells with engineered fusokines
Jiusheng Deng, Jacques Galipeau
Oncoimmunology
|
May 6, 2015
B cells for cancer immunotherapy
Jiusheng Deng, Jacques Galipeau
Plos One
|
September 9, 2014
Maltose-binding protein fusion allows for high level bacterial expression and purification of bioactive mammalian cytokine derivatives
Andrea Pennati, Jiusheng Deng, Jacques Galipeau
Lipids in Health and Disease
|
November 22, 2018
Combination of serum lipids and cancer antigens as a novel marker for colon cancer diagnosis
Tong Li, Yinfen Qian, Hongling Li, et al.
Experimental Hematology & Oncology
|
November 26, 2014
Silence of MCL-1 upstream signaling by shRNA abrogates multiple myeloma growth
Mengchang Wang, Di Wu, Pengbo Liu, et al.
Infection and Immunity
|
October 24, 2003
Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin
Jiusheng Deng, Daniel Gold, Philip T LoVerde, et al.
International Journal for Parasitology
|
November 25, 2006
Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni
Jiusheng Deng, Daniel Gold, Philip T LoVerde, et al.
Scientific Reports
|
May 26, 2016
Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells
You-Take Oh, Jiusheng Deng, Ping Yue, et al.
Oncogene
|
March 20, 2018
Monocyte chemotactic protein-induced protein-1 enhances DR5 degradation and negatively regulates DR5 activation-induced apoptosis through its deubiquitinase function
You-Take Oh, Guoqing Qian, Jiusheng Deng, et al.
Journal of Multiple Sclerosis
|
July 3, 2015
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients
Jakob Habib, Jiusheng Deng, Neil Lava, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Infectious Disorders Drug Targets
|
March 8, 2012
Reprogramming of B cells into regulatory cells with engineered fusokines
Jiusheng Deng, Jacques Galipeau
Oncoimmunology
|
May 6, 2015
B cells for cancer immunotherapy
Jiusheng Deng, Jacques Galipeau
Plos One
|
September 9, 2014
Maltose-binding protein fusion allows for high level bacterial expression and purification of bioactive mammalian cytokine derivatives
Andrea Pennati, Jiusheng Deng, Jacques Galipeau
Lipids in Health and Disease
|
November 22, 2018
Combination of serum lipids and cancer antigens as a novel marker for colon cancer diagnosis
Tong Li, Yinfen Qian, Hongling Li, et al.
Experimental Hematology & Oncology
|
November 26, 2014
Silence of MCL-1 upstream signaling by shRNA abrogates multiple myeloma growth
Mengchang Wang, Di Wu, Pengbo Liu, et al.
Infection and Immunity
|
October 24, 2003
Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin
Jiusheng Deng, Daniel Gold, Philip T LoVerde, et al.
International Journal for Parasitology
|
November 25, 2006
Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni
Jiusheng Deng, Daniel Gold, Philip T LoVerde, et al.
Scientific Reports
|
May 26, 2016
Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells
You-Take Oh, Jiusheng Deng, Ping Yue, et al.
Oncogene
|
March 20, 2018
Monocyte chemotactic protein-induced protein-1 enhances DR5 degradation and negatively regulates DR5 activation-induced apoptosis through its deubiquitinase function
You-Take Oh, Guoqing Qian, Jiusheng Deng, et al.
Journal of Multiple Sclerosis
|
July 3, 2015
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients
Jakob Habib, Jiusheng Deng, Neil Lava, et al.
Page
of 4